Paper3944462
Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma.
Girardet C and 5 others. J Immunol, 1986. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma. Papers, record 3944462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3944462
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunochemical characterization of two antigens recognized by new monoclonal antibodies against human colon carcinoma.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Antigens, Neoplasm | Major topic |
| Carcinoma | Major topic |
| Colonic Neoplasms | Major topic |
| Animals | |
| Antigen-Antibody Reactions | |
| Binding, Competitive | |
| Cell Extracts | |
| Cell Fusion | |
| Cell Line | |
| Frozen Sections | |
| Glycolipids | |
| Hematopoietic Stem Cells | |
| Humans | |
| Intestinal Mucosa | |
| Mice | |
| Mice, Inbred BALB C | |
| Precipitin Tests | |
| Radioimmunoassay | |
| Tunicamycin |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42733865 | Trop-1/EpCAM Thr115 is a driver of hyperproliferative cell repair and of severe lung damage in COVID-19. | iScience | 2026 | https://conductscience.org/library/papers/42733865 | PubMed |
| 3025856 | Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. | Proc Natl Acad Sci U S A | 1987 | https://conductscience.org/library/papers/3025856 | PubMed |
| 2726771 | Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2726771 | PubMed |
| 2658354 | Current status of tumor markers in large bowel cancer. | World J Surg | 1989 | https://conductscience.org/library/papers/2658354 | PubMed |
| 2479618 | Colonic epithelium reactive monoclonal antibodies. Identification and immunohistochemical localization of the target epitopes. | Histochemistry | 1989 | https://conductscience.org/library/papers/2479618 | PubMed |
| 2395876 | Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2395876 | PubMed |
| 2333300 | Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2333300 | PubMed |
| 2108441 | Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2108441 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3944462
GET https://conductscience.org/api/papers/v1/3944462/authors